Published in Agents Actions on September 01, 1991
Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). Agents Actions (1993) 0.76
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation. Br J Pharmacol (1996) 0.75
Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: serine-262 of the delta subunit is labeled by [3H]chlorpromazine. Proc Natl Acad Sci U S A (1986) 2.06
Overweight concerns and body dissatisfaction among third-grade children: the impacts of ethnicity and socioeconomic status. J Pediatr (2001) 1.95
Amino acid sequence of flagellin of Bacillus subtilis 168. III. Tryptic peptides, N-bromosuccinimide peptides, and the complete amino acid sequence. J Biol Chem (1976) 1.92
Amino acids of the Torpedo marmorata acetylcholine receptor alpha subunit labeled by a photoaffinity ligand for the acetylcholine binding site. Biochemistry (1988) 1.80
Amino acid analysis at the picomole level. Application to the C-terminal sequence analysis of polypeptides. Biochem J (1981) 1.76
Role for tissue factor pathway in murine model of vascular remodeling. Circ Res (2001) 1.60
Liquid chromatographic determination of amino acids after gas-phase hydrolysis and derivatization with (dimethylamino)azobenzenesulfonyl chloride. Anal Chem (1986) 1.52
Chromophoric labeling of amino acids with 4-dimethylaminoazobenzene-4'-sulfonyl chloride. Anal Chem (1975) 1.50
Transcranial Doppler assessment of cerebral flow velocity during cognitive tasks. Stroke (1992) 1.49
Addition of aprotinin to organ preservation solutions decreases lung reperfusion injury. Ann Thorac Surg (1998) 1.40
Thrombin specificity. Requirement for apolar amino acids adjacent to the thrombin cleavage site of polypeptide substrate. Eur J Biochem (1985) 1.37
Herpes simplex virus gene expression in neurons: viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathways. J Virol (1996) 1.32
Characterization of the subunits of the flagella of Proteus vulgaris. J Biol Chem (1969) 1.31
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer. Br J Cancer (2004) 1.27
Manual micro-sequence analysis of polypeptides using dimethylaminoazobenzene isothiocyanate. Methods Enzymol (1983) 1.26
Amino acid analysis in the picomole range by precolumn derivatization and high-performance liquid chromatography. Methods Enzymol (1983) 1.24
Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann Oncol (2013) 1.20
Phospholipase A2 enzymes: regulation and inhibition. Trends Pharmacol Sci (1993) 1.20
On the amino-acid sequence of flagellin from Bacillus subtilis 168: comparison with other bacterial flagellins. Proc Natl Acad Sci U S A (1973) 1.19
Antitumor agents. 120. New 4-substituted benzylamine and benzyl ether derivatives of 4'-O-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II. J Med Chem (1991) 1.15
Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice. Clin Exp Immunol (1992) 1.14
Purification of recombinant human tissue factor. Biochemistry (1989) 1.13
Strategy for the measurement of regional cerebral blood flow using short-lived tracers and emission tomography. J Cereb Blood Flow Metab (1984) 1.09
Amino-terminal analysis of polypeptide using dimethylaminoazobenzene isothiocyanate. Anal Biochem (1980) 1.09
Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan. Hum Pathol (1995) 1.07
Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anaesth (1996) 1.05
N-terminal sequence analysis of polypeptide at the picomole level. Biochem J (1981) 1.04
Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors. J Cereb Blood Flow Metab (1988) 1.04
The functional domain of hirudin, a thrombin-specific inhibitor. FEBS Lett (1983) 1.03
4-NN-dimethylaminoazobenzene 4'-isothiocyanate, a new chromophoric reagent for protein sequence analysis. Biochem J (1976) 1.02
The complete amino acid sequence of the light chain variable region of two monoclonal anti-p-azobenzene-arsonate antibodies bearing the cross-reactive idiotype. Mol Immunol (1983) 1.01
Structural and functional conservation of histidinol dehydrogenase between plants and microbes. Proc Natl Acad Sci U S A (1991) 1.01
A novel manual method for protein-sequence analysis. Biochem J (1976) 1.00
Polyethylene glycol enhanced protein refolding. Biotechnology (N Y) (1992) 1.00
Amino acid sequence of flagellin of Bacillus subtilis 168. I. Cyanogen bromide peptides. J Biol Chem (1976) 1.00
Why do neurons die when deprived of trophic factor? Neurobiol Aging (1989) 0.99
A new method for the selective isolation of cysteine-containing peptides. Specific labelling of the thiol group with a hydrophobic chromophore. Biochem J (1983) 0.99
Infection of sympathetic and sensory neurones with herpes simplex virus does not elicit a shut-off of cellular protein synthesis: implications for viral latency and herpes vectors. Neurobiol Dis (1994) 0.98
Neuronal spike activity in the nucleus accumbens of behaving rats during ethanol self-administration. Brain Res (1999) 0.98
A novel one-step purification of human alpha-thrombin after direct activation of crude prothrombin enriched from plasma. Biochem J (1991) 0.97
Preclinical evaluation of a new potent immunosuppressive agent, rapamycin. Transplantation (1991) 0.96
Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients. Cancer Chemother Pharmacol (2015) 0.96
Evaluation of antirheumatic drugs for their effect in vitro on purified human synovial fluid phospholipase A2. J Rheumatol (1991) 0.95
YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells. Br J Pharmacol (2014) 0.95
Sequence determination of eglin C using combined microtechniques of amino acid analysis, peptide isolation, and automatic Edman degradation. Anal Biochem (1983) 0.95
Preparation and characterization of proteolyzed forms of human alpha-thrombin. Thromb Res (1988) 0.95
Antithrombin III Basel. Identification of a Pro-Leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity. J Biol Chem (1986) 0.94
Rapamycin, a potential disease-modifying antiarthritic drug. J Pharmacol Exp Ther (1993) 0.94
Cerebral metabolic effects of a verbal fluency test: a PET scan study. J Clin Exp Neuropsychol (1988) 0.94
The disulfide folding pathway of hirudin elucidated by stop/go folding experiments. J Biol Chem (1993) 0.93
The structures and proteolytic specificities of autolysed human thrombin. Biochem J (1986) 0.93
Estimation of the local statistical noise in emission computed tomography. IEEE Trans Med Imaging (1982) 0.93
Chemical modification of chalcone isomerase by mercurials and tetrathionate. Evidence for a single cysteine residue in the active site. J Biol Chem (1989) 0.92
Inhibition of in vitro immunoglobulin production by rapamycin. Transplantation (1992) 0.92
Neural responses in multiple basal ganglia regions during spontaneous and treadmill locomotion tasks in rats. Exp Brain Res (2004) 0.91
Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation. Agents Actions (1989) 0.91
Heterogeneity of cross-reactive idiotypes. Serological and structural analysis of monoclonal anti-p-azobenzene-arsonate antibodies expressing major and minor idiotypes. Mol Immunol (1983) 0.91
Menadione-induced DNA damage in a human tumor cell line. Biochem Pharmacol (1991) 0.91
Isolation of isoforms of mouse prion protein with PrP(SC)-like structural properties. Biochemistry (2001) 0.90
Murine VK25 isotype sequence: monoclonal antibody 2S1.3 specific for the group A streptococcal polysaccharide. Hoppe Seylers Z Physiol Chem (1982) 0.90
Evidence that arginine-129 and arginine-145 are located within the heparin binding site of human antithrombin III. Biochemistry (1990) 0.90
Positron emission tomographic studies during serial word-reading by normal and dyslexic adults. J Clin Exp Neuropsychol (1991) 0.90
Autoregulation of cerebral blood flow in patients with orthostatic hypotension after spinal cord injury. Paraplegia (1991) 0.89
Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects. Cancer (1995) 0.89
Antitumor agents. 113. New 4 beta-arylamino derivatives of 4'-O-demethylepipodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II. J Med Chem (1990) 0.89
Manual solid phase sequence analysis of polypeptides using 4-N-N,-dimethylaminoazobenzene 4'-isothiocyanate. Biochim Biophys Acta (1979) 0.89
Inhibition of skin graft rejection in mice by rapamycin: a novel immunosuppressive macrolide. Transplant Proc (1991) 0.88
Identification in the human central nervous system, pituitary, and thyroid of a novel calcitonin gene-related peptide, and partial amino acid sequence in the spinal cord. J Biol Chem (1987) 0.88
Analysis of dimethylaminoazobenzene-thiohydantoins of amino acid by high-pressure liquid chromatography. Anal Biochem (1980) 0.87
Antitumor agents. 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4'-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II. J Med Chem (1990) 0.87
Mesolimbic neuronal activity across behavioral states. Ann N Y Acad Sci (1999) 0.87
The heparin binding site of human antithrombin III. Selective chemical modification at Lys114, Lys125, and Lys287 impairs its heparin cofactor activity. J Biol Chem (1987) 0.87
Thrombin specificity. Selective cleavage of antibody light chains at the joints of variable with joining regions and joining with constant regions. Eur J Biochem (1985) 0.87
Predominant left hemisphere metabolic dysfunction in dementia. Arch Neurol (1989) 0.86
The complete amino-acid sequence of anglerfish somatostatin-28 II. A new octacosapeptide containing the (Tyr7, Gly10) derivative of somatostatin-14 I. FEBS Lett (1984) 0.86
The destruction of serine and threonine thiohydantoins during the sequence determination of peptides by 4-N,N-dimethylaminoazobenzene 4'-isothiocyanate. Biochim Biophys Acta (1979) 0.86
Heparin binding domain of human antithrombin III inferred from the sequential reduction of its three disulfide linkages. An efficient method for structural analysis of partially reduced proteins. J Biol Chem (1989) 0.85
Involvement of specific receptors and calcium mechanisms in serotonergic contractile response of isolated cerebral and peripheral arteries from rats. J Pharmacol Exp Ther (1987) 0.85
Preliminary studies on phospholipase A2-induced mouse paw edema as a model to evaluate antiinflammatory agents. J Cell Biochem (1989) 0.85
Two behavioral states studied in a single PET/FDG procedure: theory, method, and preliminary results. J Nucl Med (1987) 0.85
Separation of 4-N,N-dimethylaminoazobenzene-4'-sulfonyl amino acids on polyamide sheets. J Chromatogr (1976) 0.85
Camptothecin resistance involving steps subsequent to the formation of protein-linked DNA breaks in human camptothecin-resistant KB cell lines. Cancer Res (1996) 0.84
Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet's disease. Br J Dermatol (2008) 0.84
Behavioral activation and the variability of cerebral glucose metabolic measurements. J Cereb Blood Flow Metab (1987) 0.84
Isolation and NH2-terminal amino acid sequences of rat serum carrier proteins for insulin-like growth factors. Biochem Biophys Res Commun (1988) 0.84
Isolation and characterization of polypeptide at the picomole level. Pre-column formation of peptide derivatives with dimethylaminoazobenzene isothiocyanate. Biochem J (1981) 0.84
A complete separation of dimethylaminoazobenzenesulphonyl-amino acids. Amino acid analysis with low nanogram amounts of polypeptide with dimethylaminoazobenzenesulphonyl chloride. Biochem J (1982) 0.84
The effect of rapamycin on kidney function in the Sprague-Dawley rat. Transplantation (1992) 0.83
The effect of Chinese medicinal herb Zingiberis rhizoma extract on cytokine secretion by human peripheral blood mononuclear cells. J Ethnopharmacol (1995) 0.83
Metabolic asymmetries in asymptomatic HIV-1 seropositive subjects: relationship to disease onset and MRI findings. J Nucl Med (1991) 0.83
Down regulation of bcl-2 by p53 in nasopharyngeal carcinoma and lack of detection of its specific t(14;18) chromosomal translocation in fixed tissues. Histopathology (1996) 0.83
Increases in both cerebral glucose utilization and blood flow during execution of a somatosensory task. Ann Neurol (1988) 0.83
High-sensitivity sequence analysis of peptides and proteins by 4-NN-dimethylaminoazobenzene 4'-isothiocyanate. Biochem J (1977) 0.83
Changes in contractile response and effect of a calcium antagonist, nimodipine, in isolated intracranial arteries of baboon following experimental subarachnoid hemorrhage. Brain Res Bull (1990) 0.82
Amino-terminal analysis with dimethylaminoazobenzene isothiocyanate. Methods Enzymol (1983) 0.82
Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity. Biochemistry (1999) 0.82
Human task-specific somatosensory activation. Neurology (1987) 0.82